Savill Corrine — SEC Form 4 filings
SEC reporting owner CIK 1837524. 6 Form 4 filings on record with FilingPulse; latest filed 2026-02-19.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-24 to 2026-02-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 120,000 shares, $1,703,308 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 40,000 shares @ $16.18 ($647,200) in Cullinan Therapeutics, Inc., filed 2024-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. (CGEM) | Chief Business Officer | 6 | — | 5 legs · 120,000 sh · $1,703,308 | 14 |
Form 4 filings — Savill Corrine
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-19 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | Cullinan Therapeutics, Inc. (CGEM) | Grant/award (A): 37,500 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Cullinan Oncology, Inc. (CGEM) | Grant/award (A): 37,500 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Cullinan Oncology, Inc. (CGEM) | Option exercise (M): 40,000 @ $4.30 · Sale (S): 40,000 @ $16.18 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2024-01-30 | 4 | Cullinan Oncology, Inc. (CGEM) | Option exercise (M): 40,000 @ $4.30 · Sale (S): 40,000 @ $14.09 · Option exercise (M): 13,997 (derivative) @ $0 · Option exercise (M): 26,003 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Cullinan Oncology, Inc. (CGEM) | Option exercise (M): 14,559 @ $4.30 · Sale (S): 14,559 @ $12.18 · Sale (S): 4,125 @ $12.02 · Option exercise (M): 21,316 @ $4.30 · Sale (S): 21,316 @ $12.46 · Option exercise (M): 14,559 (derivative) @ $0 · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1837524 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →